|Videos|March 25, 2022
Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids
Author(s)Miranda Hester
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Vaccine schedule overhaul raises concerns about delayed protection and access, says Ravi Jhaveri, MD
2
Rethinking screen time for back to school
3
Building trust may be key to vaccine conversations with hesitant families
4
Back-to-school vaccinations: What pediatricians need to know for the back-to-school season
5